UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges

Lai, EC-C; Ryan, P; Zhang, Y; Schuemie, M; Hardy, C; Kamijima, Y; Kimura, S; ... Setoguchia, S; + view all (2018) Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges. Clinical Epidemiology , 10 pp. 875-885. 10.2147/CLEP.S149961. Green open access

[thumbnail of Wong_clep-149961-applying-a-common-data-model-to-asian-databases-for-multinat-072618.pdf]
Preview
Text
Wong_clep-149961-applying-a-common-data-model-to-asian-databases-for-multinat-072618.pdf - Published Version

Download (2MB) | Preview

Abstract

Objective: The goal of the Asian Pharmacoepidemiology Network (AsPEN) is to study the effectiveness and safety of medications commonly used in Asia using databases from individual Asian countries. An efficient infrastructure to support multinational pharmacoepidemiologic studies is critical to this effort. Study Design and Setting: We converted data from the Japan Medical Data Center (JMDC) database, Taiwan’s National Health Insurance Research Database (NHIRD), Hong Kong’s Clinical Data Analysis and Reporting System (CDARS), South Korea’s Ajou University School of Medicine (AUSOM) database, and the US Medicare 5% sample to the Observational Medical Outcome Partnership (OMOP) Common Data Model. Results: We completed and documented the process for the Common Data Model (CDM) conversion. The coordinating center and participating sites reviewed the documents and refined the conversions based on the comments. The time required to convert data to the CDM varied widely across sites and included conversion to standard terminology codes and refinements of the conversion based on reviews. We mapped 97.2%, 86.7%, 92.6%, and 80.1% of domestic drug codes from the United States, Taiwan, Hong Kong, and Korea to RxNorm, respectively. The mapping rate from Japanese domestic drug codes to RxNorm (70.7%) was lower than from other countries, and we mapped remaining unmapped drugs to Anatomical Therapeutic Chemical Classification System codes. Because the native databases used international procedure codingsystems for which mapping tables have been established, we were able to map more than 90% of diagnosis and procedure codes to standard terminology codes. Conclusion: The Common Data Model established the foundation and reinforced collaboration for multinational pharmacoepidemiologic studies in Asia. Mapping of terminology codes was the greatest challenge, because of differences in health systems, cultures, and coding systems.

Type: Article
Title: Applying a common data model to Asian databases for multinational pharmacoepidemiologic studies: opportunities and challenges
Open access status: An open access version is available from UCL Discovery
DOI: 10.2147/CLEP.S149961
Publisher version: https://doi.org/10.2147/CLEP.S149961
Language: English
Additional information: This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (https://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Keywords: clinical coding, computer communication networks, feasibility studies, pharmacoepidemiology, pharmacovigilance
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Practice and Policy
URI: https://discovery.ucl.ac.uk/id/eprint/10045332
Downloads since deposit
222Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item